Organ Transplantation | Natera

IN THE NEWS

New ProActive Registry: largest clinical utility study evaluating Prospera in >3K kidney transplant patients.

COVID-19 UPDATE

Get a blood draw in the comfort of your own home.


ORGAN TRANSPLANTATION & HEALTH

Natera uses revolutionary technology to enhance the patient and physician's ability to assess otherwise undetected rejection events that might lead to loss of the transplanted organ, in addition to solutions to better manage chronic kidney disease.


1

Track the health of your transplanted organ

Prospera is optimized to be the most precise cfDNA tool for early, clinically meaningful rejection assessment.

2

Personalizing chronic kidney disease

Comprehensive genetic panel to inform and tailor management strategies.


IN THE NEWS

Listen to our founder, Matthew Rabinowitz Ph.D., talk about his experience starting Natera and discovering applications of cell-free DNA in pregnancy, cancer, and now transplantation.

Watch the Video


IN THE NEWS

Natera announces agreement with OneLambda to co-distribute Prospera transplant assessment test.

Learn More